Atlas Trials

Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Clinical trial NCT00747799 · COMPLETED

Trial details

NCT number
NCT00747799
Sponsor
Sun Yat-sen University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Neoplasms
Start date
2009-01-01
Primary completion
2011-05-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.